HYEX.US Grey Cloak Tech Inc

Healthcare Pharmaceuticals USA Stocks
1.35 USD
Close of Nov 15, 2026
0.8209 2.70
Market cap
USD 19.9M
P/E
-
P/B
0.89x
ROE
-2.9%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is HYEX.US undervalued?

Graham number

The Graham number of Grey Cloak Tech Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Grey Cloak Tech Inc fundamental analysis

No fundamental analysis for Grey Cloak Tech Inc yet.

Grey Cloak Tech Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Grey Cloak Tech Inc

Healthy Extracts Inc., through its subsidiaries, engages in acquiring, developing, patenting, marketing, and distributing plant-based nutraceuticals in the United States. It operates through Corporate and Health Supplements segments. The company's proprietary and patented products target categories within the nutraceuticals market, such as heart, brain, and immune health. It also provides heart and immune health products, including bergamot-based products in tablet and capsu…

Full company profile